Jian Zhou
About Jian Zhou
Jian Zhou is a Senior Research Investigator at Bristol-Myers Squibb, specializing in model-based meta-analyses in Clinical Pharmacology & Pharmacometrics. He holds a Ph.D. in Pharmaceutical Sciences from the University of Houston and has extensive experience in research and quality assurance roles.
Current Title and Role
Jian Zhou holds the position of Senior Research Investigator at Bristol-Myers Squibb. As a Senior Research Investigator, Jian Zhou operates out of Princeton, NJ, engaging in advanced research activities within the pharmaceutical sector. This role involves detailed investigations and model-based meta-analyses within the field of Clinical Pharmacology and Pharmacometrics.
Previous Professional Experience
Before joining Bristol-Myers Squibb, Jian Zhou accumulated diverse experience at several notable organizations. Zhou served as a Research Scientist I at Tetraphase Pharmaceuticals from 2017 to 2019 in Watertown, MA. Additionally, Zhou interned at Achaogen in the San Francisco Bay Area for two months in 2017. Prior to these, Zhou was a Research Assistant at the University of Houston for three years and also briefly held a Teaching Assistant position there in 2014.
Years in Quality Assurance
Jian Zhou's early career years were spent in quality assurance. From 2007 to 2011, Zhou worked as a Quality Assurance (QA) Technician at Jinling Pharmaceutical Co., Ltd. in Nanjing, Jiangsu, China. In this role, Zhou was responsible for ensuring the quality and compliance of pharmaceutical products with industry standards and regulations.
Education and Academic Background
Jian Zhou has a robust educational background in pharmaceutical sciences and pharmacology. Zhou earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Houston, completing the program between 2014 and 2017. Zhou also holds a Bachelor of Science (B.S.) in Pharmacology from China Pharmaceutical University, earned between 2002 and 2006.
Specialization in Model-Based Meta-Analyses
Jian Zhou specializes in model-based meta-analyses (MBMA) within the field of Clinical Pharmacology and Pharmacometrics. This specialization involves the use of statistical models to analyze and combine results from different studies, enhancing the understanding of drug efficacy and safety profiles. Zhou's work in this area contributes to the optimization of drug development and therapeutic strategies.